Anti Covid pill, Merck challenges Pfizer: “Soon the request to the FDA”

Anti Covid pill, Merck challenges Pfizer: “Soon the request to the FDA”
Anti Covid pill, Merck challenges Pfizer: “Soon the request to the FDA”

Merck accelerates the process to bring the Covid-19 treatment pill to market and challenges Pfizer. The pharmaceutical company has in fact published the first results of the trial which showed a 50% reduction in the risk of hospitalization and deaths of people infected with the coronavirus.

Merck (MSD in Italy) and partner Ridgeback Biotherapeutics have announced that they will soon ask the US FDA to authorize the use of the drug, molnupiravir, in the United States in an emergency as soon as possible.

PREV At the Swank Rally with the Ténéré 700: here’s how it went! – Sports
NEXT Pesaro, from Eden Viaggi Pesaro to the new tour operator ‘Creo’ – Chronicle